-
Glimmer Of Hope: This Alzheimer Drug Failed In A Clinical Trial, But Still Shows Promise Of Halting Disease Progression
Friday, July 29, 2016 - 11:02am | 312Read More...LMTX, a drug designed to battle the effects of Alzheimer's disease, recently failed a large phase III trial, but did show signs of success when the drug was given to people who are already taking other Alzheimer medications. The drug is produced by a company called TauRX Pharmaceuticals. According...


